L Wu, MA Martínez-Castellanos, H Quiroz- … - Graefe's Archive for Clinical and Experimental …, 2008 - Springer Abstract Background Vascular endothelial growth factor (VEGF) plays an important
role in many diseases of the posterior pole that are characterized by macular
edema and/or intraocular neovascularization. Recently anti-VEGF agents such ... Cited by 65 - Related articles - BL Direct - All 2 versions
MS Ip, IU Scott, GC Brown, MM Brown, AC Ho … - Ophthalmology, 2008 - Elsevier Literature searches were conducted in May and October 2007 in PubMed with no
date restrictions, limited to articles published in English, and in the Cochrane
Central Register of Controlled Trials without a language limitation and ... Cited by 13 - Related articles - All 5 versions
S Grisanti, F Ziemssen - Indian Journal of Ophthalmology, 2007 - pubmedcentral.nih.gov Bevacizumab is a full-length, humanized monoclonal antibody directed against all
the biologically active isoforms of vascular endothelial growth factor (VEGF-A).
The antibody was initially designed and studied as an anti-angiogenic ... Cited by 5 - Related articles - BL Direct - All 4 versions
JB Gunther, MM Altaweel - Survey of Ophthalmology, 2009 - Elsevier The use of intravitreal bevacizumab (Avastin) has greatly expanded since its
introduction into ophthalmic care 3 years ago. A PubMed search on 1 August 2008
revealed 51 ocular disease processes that have been treated with ... Cited by 2 - Related articles - All 23 versions
- ►duanessolution.com MW Stewart - Techniques in Ophthalmology, 2007 - journals.lww.com Age-related macular degeneration, diabetic retinopathy, and retinal venous
occlusive disease are among the leading causes of blindness. Despite their
differing appearances, they share common biochemical abnormalities, ... Related articles - All 4 versions
S Soudry, A Loewenstein, J Moisseiev - Retinal Cases and Brief Reports, 2009 - pdfs.journals.lww.com Intravitreal injection of bevacizumab, an antivascular endothelial growth factor
antibody, has become common practice in the treatment of neovascular age-
related macular degeneration.1,2 This route of admin- istration may be ... Related articles - All 3 versions
В Јакшић, Л Жорић, М Мирковић, Д … - medf.pr.ac.yu Exudative age-related macular degeneration is leading cause of irreversible
vision loss in developed countries. Subfoveal localisation of choroidal
neovascular membrane is the most difficult form for treatment. At the last ... Related articles - View as HTML - All 2 versions